Given the well‐established role of oncogenic transcription factors such as AR and ASCL1 in driving prostate cancer,[17, 23] our investigation extended to evaluating the contribution of novel lineage‐related TFs to cell growth and aggressiveness. This evidence concerns the gene ASCL1 and Familial prostate cancer.